Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.51 | -16.72 |
PEG Ratio (TTM) | -0.11 | -4.96 |
P/S Ratio (TTM) | 2.44 | 47.85 |
P/B Ratio (TTM) | 0.87 | 27.92 |
P/FCF Ratio (TTM) | -2.10 | -4.60 |
Price to 5YR AVG Earnings Ratio | -1.03 | -5.71 |
Price to 5YR AVG FCF Ratio | -5.47 | -12.95 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -50.67% | -16.97% |
ROE (TTM) | -49.49% | 27.85% |
Net Profit Margin (TTM) | -161.58% | -848.99% |
ROIC 5YR AVG | -276.54% | -22.40% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.77% | 60.00% | 47.27% |
Revenue | 3.18% | 875.32% | 544.36% |
Net Income | 11.53% | -12.56% | -3.52% |
Cash Flow | 9.40% | 7.76% | 7.33% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.96 | 5.79 |
Quick Ratio (TTM) | 6.96 | 5.57 |
D/E Ratio (TTM) | N/A | 0.93 |
Interest Coverage (TTM) | -74.39 | -7.43 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 12.96 |
LTL to 5YR AVG FCF | N/A | 0.11 |
Shares Outstanding Growth 5YR AVG | 101.62% | 43.03% |